Deletion of the gag region from FBR murine osteosarcoma virus does not affect its enhanced transforming activity
- PMID: 2991577
- PMCID: PMC254997
- DOI: 10.1128/JVI.55.3.521-526.1985
Deletion of the gag region from FBR murine osteosarcoma virus does not affect its enhanced transforming activity
Abstract
Both FBJ murine osteosarcoma virus (FBJ-MSV) and FBR-MSV induce transformation in tissue culture and osteogenic sarcomas in mice. In tissue culture, however, FBR-MSV induces larger foci with a shorter latency than those induced by FBJ-MSV. Transformation is dependent on expression of the fos oncogene in FBJ-MSV and of a gag-fos fusion protein in FBR-MSV. We have determined that the gag sequences can be deleted from FBR-MSV without affecting the high transforming activity of this virus in comparison to FBJ-MSV. The resultant virus, designated FBJ/R-MSV, has a protein coding region that is half the size of that of FBR-MSV and about one-third smaller than that of FBJ-MSV. Thus, FBJ/R-MSV will provide a useful tool for studying the transforming activity of the fos oncogene.
Similar articles
-
FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product.Virology. 1984 May;135(1):218-28. doi: 10.1016/0042-6822(84)90132-6. Virology. 1984. PMID: 6203214
-
Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells.Mol Cell Biol. 1983 May;3(5):914-21. doi: 10.1128/mcb.3.5.914-921.1983. Mol Cell Biol. 1983. PMID: 6306448 Free PMC article.
-
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.J Virol. 1982 Nov;44(2):674-82. doi: 10.1128/JVI.44.2.674-682.1982. J Virol. 1982. PMID: 6292525 Free PMC article.
-
Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses.Biochem Pharmacol. 2002 Sep;64(5-6):957-61. doi: 10.1016/s0006-2952(02)01159-0. Biochem Pharmacol. 2002. PMID: 12213592 Review.
-
Towards a biochemical description of malignant transformation. Identification and functional characterization of the Rous sarcoma virus transforming gene product.Cancer. 1984 May 15;53(10):2041-5. doi: 10.1002/1097-0142(19840515)53:10<2041::aid-cncr2820531006>3.0.co;2-x. Cancer. 1984. PMID: 6322956 Review. No abstract available.
Cited by
-
Role of gag sequence in the biochemical properties and transforming activity of the avian sarcoma virus UR2-encoded gag-ros fusion protein.J Virol. 1990 Dec;64(12):5997-6009. doi: 10.1128/JVI.64.12.5997-6009.1990. J Virol. 1990. PMID: 2173777 Free PMC article.
-
Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteins.J Virol. 2003 Mar;77(5):2850-8. doi: 10.1128/jvi.77.5.2850-2858.2003. J Virol. 2003. PMID: 12584308 Free PMC article.
-
The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.J Virol. 1986 Aug;59(2):224-33. doi: 10.1128/JVI.59.2.224-233.1986. J Virol. 1986. PMID: 3525854 Free PMC article.
-
Putative phosphatidylinositol 3-kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt activation.J Virol. 2003 Jul;77(14):7924-35. doi: 10.1128/jvi.77.14.7924-7935.2003. J Virol. 2003. PMID: 12829832 Free PMC article.
-
Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation.Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4443-8. doi: 10.1073/pnas.071572898. Proc Natl Acad Sci U S A. 2001. PMID: 11296287 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources